From: Faecalibacterium prausnitzii as a potential Antiatherosclerotic microbe
Variable | MI (n = 53) | UA (n = 106) | SCAD (n = 56) | Control (n = 156) | P value |
---|---|---|---|---|---|
Age, yr * | 60 ± 12 | 60 ± 11 | 60 ± 10 | 57 ± 11 | 0.56 |
Male,n # | 43 (81.13%) | 70 (66.04%) | 33 (58.93%) | 77 (49.36%) | < 0.001 a b |
Body mass index, kg/m2+ | 25.69 (3.81) | 25.14 (5.1) | 25.15 (4.84) | 25 (5.48) | 0.828 |
Systolic blood pressure, mmHg + | 128 (22) | 131 (24) | 124 (27) | 124 (22) | 0.021 b |
diastolic blood pressure, mmHg + | 77 (16) | 76 (16) | 73 (17) | 75 (12) | 0.51 |
Smoking status |  |  |  |  | < 0.001a e |
Never or Past # | 31 (58.49%) | 62 (58.49%) | 38 (67.86%) | 127 (81.41%) | Â |
Current # | 22 (41.51%) | 44 (41.51%) | 18 (32.14%) | 29 (18.59%) | Â |
Drinking status |  |  |  |  | < 0.001a b |
 Non-heavy Drinker # | 25 (47.17%) | 73 (68.87%) | 38 (67.86%) | 123 (78.85%) |  |
 Heavy Drinker # | 28 (52.83%) | 33 (31.13) | 18 (32.14%) | 33 (21.15%) |  |
Basic diseases | Â | Â | Â | Â | Â |
 Hypertension # | 35 (66.04%) | 63 (59.43%) | 37 (66.07%) | 65 (41.67%) | 0.001a b c |
 Diabetes # | 23 (43.4%) | 34 (32.08%) | 17 (30.36%) | 21 (13.46%) | < 0.001a b c |
Long term oral medication | Â | Â | Â | Â | Â |
 Aspirin # | 46 (86.79%) | 88 (83.02%) | 42 (75%) | 60 (38.46%) | < 0.001a b c |
 Clopidogrel # | 33 (62.26%) | 69 (65.09%) | 37 (66.07%) | 8 (5.13%) | < 0.001a b c |
 Stain # | 44 (83.02%) | 81 (76.42%) | 47 (82.93%) | 67 (42.95%) | < 0.001a b c |
 β-block # | 38 (71.7%) | 64 (60.38%) | 34 (60.71%) | 46 (29.49%) | < 0.001a b c |
 Calcium Channel Blockers # | 8 (15.09%) | 26 (24.53%) | 17 (30.36%) | 29 (18.59%) | 0.155 |
 ACEI or ARB # | 25 (47.17%) | 37 (34.91%) | 26 (46.43%) | 35 (22.44%) | 0.001a c |
Laboratory results | Â | Â | Â | Â | Â |
 Blood Urea Nitrogen, mmol/L + | 5.05 (2.73) | 5.11 (2.1) | 5.4 (1.4) | 5.05 (1.8) | 0.26 |
 Creatinine, umol/L + | 71.5 (20.28) | 66 (23) | 62 (22.84) | 62 (19) | < 0.001a d e |
 Uric Acid, umol/L + | 333 (141.25) | 308 (109) | 327 (123) | 310 (111) | 0.111 |
 Glucose, mmol/L + | 5.29 (2.87) | 5.19 (2.07) | 4.84 (1.9) | 4.76 (0.82) | < 0.001a b |
 Triglyceride, mmol/L + | 1.48 (1.03) | 1.37 (0.99) | 1.57 (1.18) | 1.32 (0.88) | 0.114 |
 Total cholesterol, mmol/L + | 3.47 (1.36) | 3.34 (1.26) | 3.42 (1.29) | 3.96 (1.18) | 0.001b |
 High Density Lipoprotein, mmol/L + | 1.04 (0.31) | 1.02 (0.39) | 1.06 (0.41) | 1.14 (0.46) | 0.002a b |
 Low Density Lipoprotein, mmol/L + | 2.09 (1.31) | 2.03 (1.05) | 1.84 (1.17) | 2.53 (1.06) | < 0.001b c |
 Apolipoprotein AI, g/L * | 0.99 ± 0.22 | 1.0 ± 0.33 | 1.1 ± 0.29 | 1.1 ± 0.28 | 0.002a b |
 Apolipoprotein B, g/L * | 0.91 ± 0.31 | 0.87 ± 0.29 | 0.89 ± 0.31 | 0.96 ± 0.29 | 0.08 |
 Lipoprotein(a), mg/L + | 195.02 (247.72) | 125.89 (245.44) | 123.2 (161.8) | 105.35 (180.23) | 0.124 |